financing Helix Raises $50M in Series C Financing The company plans to use the new funding to accelerate the use of its population genomics platform and to support its COVID-19 testing and viral surveillance efforts. Clear Labs Raises $60M in Series C Financing Round The funds will be used to help broaden the availability of the company's solutions to identify and trace all strains of pathogens, such as SARS-CoV-2. Caris Life Sciences Raises $830M to Support Precision Medicine Platform, Liquid Biopsy Development The funds will help support Caris' ongoing commercial efforts in comprehensive cancer genomics as it makes new forays into liquid biopsy for multi-cancer early detection. Oxford Nanopore Technologies Raises £195M In late March, the nanopore sequencing firm said it plans an initial public offering on the London Stock Exchange later this year. Genome Editing Company EdiGene Raises RMB 400M in Series B Plus Financing Round The Beijing-headquartered company will use the proceeds to advance its pipeline of genome editing technologies into clinics and to scale up business operations. Apr 15, 2021 Cancer Dx Firm C2i Genomics Raises $100M in Financing Apr 14, 2021 Benchling Raises $200M in Series E Funding Round Apr 14, 2021 NantHealth Lands $137.5M in Financing to Extend Debt Maturity Date Apr 7, 2021 Nucleix Raises $55M in Financing Round Apr 6, 2021 Scottish Liquid Biopsy Startup BioCaptiva Raises £1M in Seed Funding Apr 5, 2021 Inscripta Closes $150M Series E Financing Round Mar 24, 2021 Scipher Medicine Raises $82M in Series C Financing Mar 24, 2021 QuantuMDx Raises $15.1M to Support Scale Up of Point-of-Care Molecular Diagnostic System Mar 23, 2021 CellMax Life, Sebela Pharmaceuticals Sign Commercial Agreement for Colorectal Cancer Dx Test Mar 16, 2021 Genomenon Raises $5.3M in Financing Round Mar 16, 2021 NephroSant Raises $16M in Series A Funding Round Mar 15, 2021 Variantyx Raises $20M in Series C Financing Mar 4, 2021 PerkinElmer to Offer $800M in Senior Notes Feb 25, 2021 Miroculus Raises $45M in Extended Series B Financing Feb 24, 2021 WuXi Diagnostics Closes $150M Series B Financing Round Feb 23, 2021 AnchorDx Closes $40M Series C Financing Round Feb 10, 2021 Pacific Biosciences to Obtain $900M Investment From SoftBank Subsidiary Feb 10, 2021 Personal Genome Diagnostics Raises $103M in Series C Financing Feb 8, 2021 Illumina Adds Nine Startups to Accelerator Program, Announces £20M Matching Fund Feb 4, 2021 Inivata Raises $35M in Second Close of Series C Financing Round Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.